What approach does the Centers for Disease Control and Prevention (CDC) recommend when tapering opioid dosages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CDC Recommendations for Tapering Opioid Dosages

The CDC recommends gradual tapering of opioid dosages at a rate of no greater than 10% per month for patients on long-term therapy, with close patient collaboration and frequent follow-up, while avoiding abrupt discontinuation or rapid dose reduction. 1

Key CDC Recommendations for Opioid Tapering

Assessment and Decision-Making

  • Carefully weigh both benefits and risks of continuing opioid therapy versus tapering
  • Use shared decision-making with patients when benefits and risks are unclear
  • Acknowledge discordance when patients and clinicians disagree about tapering, while avoiding patient abandonment

Tapering Approach

  • For patients on long-term opioid therapy (≥1 year):
    • Implement tapers of 10% per month or slower
    • Complete tapers over several months to years depending on dosage
    • Individualize based on patient goals and concerns 1

Tapering Implementation

  • Collaborate with patients on the tapering plan, including:
    • Tapering speed
    • When pauses might be warranted
    • Follow up at least monthly during tapering 1
  • Use a taper slow enough to minimize withdrawal symptoms
  • Utilize team members (nurses, pharmacists, behavioral health professionals) to support the process
  • Maximize nonopioid pain treatments during tapering

Warning Signs and Adjustments

  • Slow the taper if clinically significant withdrawal symptoms occur
  • Pause and restart tapers when patients are ready
  • Slow the taper as patients reach lower dosages
  • Carefully assess benefits and risks before reversing a taper 1

Important Cautions

  • Never discontinue opioids abruptly unless there are life-threatening issues (e.g., confusion, sedation, slurred speech)
  • Never rapidly reduce opioid dosages from higher dosages 1
  • Monitor for withdrawal symptoms including:
    • Anxiety, insomnia, abdominal pain, vomiting, diarrhea
    • Diaphoresis, mydriasis, tremor, tachycardia, piloerection 1, 2
  • Watch for changes in mood, suicidal thoughts, or substance use during tapering 2

Special Considerations

  • Consult appropriate specialists when tapering opioids during pregnancy due to risks to both mother and fetus 1
  • Provide opioid overdose education and offer naloxone to patients undergoing dose reduction 1
  • For patients who have taken opioids for briefer periods, a more rapid taper may be tolerated 2

The CDC's 2022 guidelines emphasize a patient-centered approach to opioid tapering that prioritizes safety, minimizes withdrawal symptoms, and maintains quality of life while reducing opioid dosages when appropriate.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.